Century Therapeutics, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Carr Douglas | SVP Finance & Operations | Award / Grant | 14,000 | — | — | 317,580 | Mar 7, 2024 |
| Russotti Gregory | See Remarks | Award / Grant | 24,000 | — | — | 302,319 | Mar 7, 2024 |
| Farid Adrienne | Chief Operations Officer | Award / Grant | 24,000 | — | — | 138,149 | Mar 7, 2024 |
| Levitsky Hyam | President of R&D | Award / Grant | 24,000 | — | — | 24,000 | Mar 7, 2024 |
| Farid Adrienne | Chief Operations Officer | Option Exercise | 30,684 | $1.03 | $31,605 | 144,833 | Mar 7, 2024 |
| Farid Adrienne | Chief Operations Officer | Option Exercise | 485 | $1.03 | $500 | 114,634 | Feb 16, 2024 |
| Carr Douglas | SVP Finance & Operations | Sale | 643 | $3.84 | $2,469 | 304,137 | Feb 6, 2024 |
| Farid Adrienne | Chief Operations Officer | Sale | 1,784 | $4.49 | $8,010 | 114,149 | Feb 5, 2024 |
| Pfeiffenberger Brent | President and CEO | Award / Grant | 279,504 | — | — | 1,453,279 | Dec 4, 2023 |
| Carr Douglas | SVP Finance & Operations | Tax Withholding | 16,611 | $1.49 | $24,750 | 304,780 | Nov 1, 2023 |
| Diem Michael Craig | Chief Financial Officer | Tax Withholding | 20,763 | $1.49 | $30,937 | 253,533 | Nov 1, 2023 |
| Carr Douglas | SVP Finance & Operations | Award / Grant | 120,846 | — | — | 321,391 | May 15, 2023 |
| Diem Michael Craig | Chief Financial Officer | Award / Grant | 151,058 | — | — | 274,296 | May 15, 2023 |
| Borges Luis | Chief Scientific Officer | Option Exercise | 7,452 | $1.03 | $7,676 | 256,535 | Apr 3, 2023 |
| Borges Luis | Chief Scientific Officer | Sale | 65,698 | $3.72 | $244,397 | 43,750 | Mar 23, 2023 |
| Carr Douglas | VP Finance & Operations | Award / Grant | 7,500 | — | — | 193,045 | Feb 2, 2023 |
| Borges Luis | Chief Scientific Officer | Award / Grant | 21,875 | — | — | 21,875 | Feb 2, 2023 |
| Farid Adrienne | Chief Operations Officer | Award / Grant | 21,875 | — | — | 96,093 | Feb 2, 2023 |
| Diem Michael Craig | Chief Business Officer | Award / Grant | 21,875 | — | — | 101,363 | Feb 2, 2023 |
| Versant Vantage II GP, L.P. | — | Sale | 550,000 | $13.03 | $7,166,500 | 11,816,814 | Aug 9, 2022 |
| Versant Ventures VI GP-GP, LLC | — | Other | 178,996 | — | — | 12,366,814 | Jan 31, 2022 |
| Versant Vantage II, L.P. | — | Other | 371,004 | — | — | 12,545,810 | Dec 23, 2021 |
| Casdin Eli | — | Purchase | 750,000 | $20.00 | $15,000,000 | 3,206,380 | Jun 22, 2021 |
| Versant Vantage II, L.P. | — | Purchase | 100,000 | $20.00 | $2,000,000 | 714,095 | Jun 22, 2021 |
| BAYER AKTIENGESELLSCHAFT | — | Purchase | 750,000 | $20.00 | $15,000,000 | 12,675,838 | Jun 22, 2021 |
| FUJIFILM Holdings Corp | — | C | 3,974,404 | — | — | 6,955,207 | Jun 22, 2021 |